The firm shows Beta (market volatility) of 0.0 which signifies that the returns on MARKET and Avon Lifesciences are completely uncorrelated. Although it is extremely important to respect Avon Lifesciences historical returns, it is better to be realistic regarding the information on equity current trending patterns. The philosophy towards foreseeing future performance of any stock is to evaluate the business as a whole together with its past performance including all available fundamental and technical indicators. By analyzing Avon Lifesciences technical indicators you can presently evaluate if the expected return of 0.0% will be sustainable into the future. Avon Lifesciences right now shows a risk of 0.0%. Please confirm Avon Lifesciences Coefficient Of Variation, Treynor Ratio as well as the relationship between Treynor Ratio and Semi Variance to decide if Avon Lifesciences will be following its price patterns.
Over the last 30 days Avon Lifesciences Limited has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound fundamental drivers, Avon Lifesciences is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.
|Horizon||30 Days Login to change|
Avon Lifesciences Relative Risk vs. Return LandscapeIf you would invest 780.00 in Avon Lifesciences Limited on May 19, 2019 and sell it today you would earn a total of 0.00 from holding Avon Lifesciences Limited or generate 0.0% return on investment over 30 days. Avon Lifesciences Limited is generating negative expected returns and assumes 0.0% volatility on return distribution over the 30 days horizon. Simply put, 0% of equities are less volatile than Avon Lifesciences and 99% of equity instruments are likely to generate higher returns than the company over the next 30 trading days.
Daily Expected Return (%)
Avon Lifesciences Market Risk Analysis
Sharpe Ratio = 0.0